196 related articles for article (PubMed ID: 20668862)
1. The role of inflammation in the genesis of the cystic component of craniopharyngiomas.
Pettorini BL; Inzitari R; Massimi L; Tamburrini G; Caldarelli M; Fanali C; Cabras T; Messana I; Castagnola M; Di Rocco C
Childs Nerv Syst; 2010 Dec; 26(12):1779-84. PubMed ID: 20668862
[TBL] [Abstract][Full Text] [Related]
2. Cystic craniopharyngioma: intratumoral chemotherapy with alpha interferon.
Dastoli PA; Nicácio JM; Silva NS; Capellano AM; Toledo SR; Ierardi D; Cavalheiro S
Arq Neuropsiquiatr; 2011 Feb; 69(1):50-5. PubMed ID: 21359423
[TBL] [Abstract][Full Text] [Related]
3. Proteomics in pediatric cystic craniopharyngioma.
Massimi L; Martelli C; Caldarelli M; Castagnola M; Desiderio C
Brain Pathol; 2017 May; 27(3):370-376. PubMed ID: 28414889
[TBL] [Abstract][Full Text] [Related]
4. Intracystic bleomycin for cystic craniopharyngiomas in children.
Zhang S; Fang Y; Cai BW; Xu JG; You C
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008890. PubMed ID: 27416004
[TBL] [Abstract][Full Text] [Related]
5. Use of interferon alpha in intratumoral chemotherapy for cystic craniopharyngioma.
Cavalheiro S; Dastoli PA; Silva NS; Toledo S; Lederman H; da Silva MC
Childs Nerv Syst; 2005 Aug; 21(8-9):719-24. PubMed ID: 16133276
[TBL] [Abstract][Full Text] [Related]
6. Craniopharyngiomas: A systematic review and evaluation of the current intratumoral treatment landscape.
Mrowczynski OD; Langan ST; Rizk EB
Clin Neurol Neurosurg; 2018 Mar; 166():124-130. PubMed ID: 29408768
[TBL] [Abstract][Full Text] [Related]
7. Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN.
Kilday JP; Caldarelli M; Massimi L; Chen RH; Lee YY; Liang ML; Parkes J; Naiker T; van Veelen ML; Michiels E; Mallucci C; Pettorini B; Meijer L; Dorfer C; Czech T; Diezi M; Schouten-van Meeteren AYN; Holm S; Gustavsson B; Benesch M; Müller HL; Hoffmann A; Rutkowski S; Flitsch J; Escherich G; Grotzer M; Spoudeas HA; Azquikina K; Capra M; Jiménez-Guerra R; MacDonald P; Johnston DL; Dvir R; Constantini S; Kuo MF; Yang SH; Bartels U
Neuro Oncol; 2017 Oct; 19(10):1398-1407. PubMed ID: 28499018
[TBL] [Abstract][Full Text] [Related]
8. Intracystic interferon-α treatment leads to neurotoxicity in craniopharyngioma: case report.
Sharma J; Bonfield CM; Singhal A; Hukin J; Steinbok P
J Neurosurg Pediatr; 2015 Sep; 16(3):301-4. PubMed ID: 26023721
[TBL] [Abstract][Full Text] [Related]
9. Intracystic bleomycin for cystic craniopharyngiomas in children.
Zheng J; Fang Y; Cai BW; Zhang H; Liu W; Wu B; Xu JG; You C
Cochrane Database Syst Rev; 2014 Sep; (9):CD008890. PubMed ID: 25233847
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic transventricular positioning of intracystic catheter for treatment of craniopharyngioma. Technical note.
Pettorini BL; Tamburrini G; Massimi L; Caldarelli M; Di Rocco C
J Neurosurg Pediatr; 2009 Sep; 4(3):245-8. PubMed ID: 19772408
[TBL] [Abstract][Full Text] [Related]
11. Proteomic characterization of pediatric craniopharyngioma intracystic fluid by LC-MS top-down/bottom-up integrated approaches.
Martelli C; Iavarone F; Vincenzoni F; Rossetti DV; D'Angelo L; Tamburrini G; Caldarelli M; Di Rocco C; Messana I; Castagnola M; Desiderio C
Electrophoresis; 2014 Aug; 35(15):2172-83. PubMed ID: 24729313
[TBL] [Abstract][Full Text] [Related]
12. Pegylated interferon-α-2b for children with recurrent craniopharyngioma.
Yeung JT; Pollack IF; Panigrahy A; Jakacki RI
J Neurosurg Pediatr; 2012 Dec; 10(6):498-503. PubMed ID: 23061825
[TBL] [Abstract][Full Text] [Related]
13. Intracystic bleomycin for cystic craniopharyngiomas in children.
Fang Y; Cai BW; Zhang H; Liu W; Wu B; Xu JG; You C
Cochrane Database Syst Rev; 2012 Apr; (4):CD008890. PubMed ID: 22513968
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral therapy with bleomycin for cystic craniopharyngiomas in children.
Hader WJ; Steinbok P; Hukin J; Fryer C
Pediatr Neurosurg; 2000 Oct; 33(4):211-8. PubMed ID: 11124639
[TBL] [Abstract][Full Text] [Related]
15. Visual Field Loss in a Case of Recurrent Cystic Craniopharyngioma During Concomitant Treatment With Pegylated Interferon α-2b.
Tiedemann LM; Manley P; Smith ER; Dagi LR
J Pediatr Hematol Oncol; 2016 Jan; 38(1):e26-8. PubMed ID: 26558808
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis in alpha interferon (IFN-alpha) intratumoral chemotherapy for cystic craniopharyngiomas.
Ierardi DF; Fernandes MJ; Silva IR; Thomazini-Gouveia J; Silva NS; Dastoli P; Toledo SR; Cavalheiro S
Childs Nerv Syst; 2007 Sep; 23(9):1041-6. PubMed ID: 17593372
[TBL] [Abstract][Full Text] [Related]
17. Dense cystic craniopharyngiomas.
Braun IF; Pinto RS; Epstein F
AJNR Am J Neuroradiol; 1982; 3(2):139-41. PubMed ID: 6803547
[TBL] [Abstract][Full Text] [Related]
18. Intracystic treatments for craniopharyngioma.
Steinbok P; Hukin J
Neurosurg Focus; 2010 Apr; 28(4):E13. PubMed ID: 20367357
[TBL] [Abstract][Full Text] [Related]
19. Fatal toxic effect of bleomycin on brain tissue after intracystic chemotherapy for a craniopharyngioma: case report.
Savas A; Erdem A; Tun K; Kanpolat Y
Neurosurgery; 2000 Jan; 46(1):213-6; discussion 216-7. PubMed ID: 10626953
[TBL] [Abstract][Full Text] [Related]
20. Phase II evaluation of interferon-alpha-2a for progressive or recurrent craniopharyngiomas.
Jakacki RI; Cohen BH; Jamison C; Mathews VP; Arenson E; Longee DC; Hilden J; Cornelius A; Needle M; Heilman D; Boaz JC; Luerssen TG
J Neurosurg; 2000 Feb; 92(2):255-60. PubMed ID: 10659012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
